SCHEMBL7032782

SCHEMBL7032782

CCCCCCCC/C=C/CCCCCCCCN=C=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.52
TRPV1 Q8NER1 1/20 0.52
NAAA Q02083 1/20 0.47
TERT O14746 3/20 0.46
PTPN1 P18031 3/20 0.46
PPARG P37231 3/20 0.46
PPARD Q03181 3/20 0.46
PPARA Q07869 3/20 0.46
TOP1 P11387 3/20 0.46
CYP1A2 P05177 2/20 0.46
MAPT P10636 2/20 0.46
CYP2C19 P33261 2/20 0.46
BLM P54132 2/20 0.46
HSD17B10 Q99714 2/20 0.46
FABP4 P15090 2/20 0.46
KMT2A Q03164 2/20 0.46
GMNN O75496 1/20 0.46
USP2 O75604 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7029381 1.00 FAAH (0.52) FAAHTRPV1NAAATERTPTPN1
SCHEMBL7032914 1.00 FAAH (0.52) FAAHTRPV1NAAATERTPTPN1
SCHEMBL22578571 1.00 FAAH (0.52) FAAHTRPV1NAAATERTPTPN1
SCHEMBL7034321 1.00 FAAH (0.52) FAAHTRPV1NAAATERTPTPN1
SCHEMBL37878 1.00 FAAH (0.52) FAAHTRPV1NAAATERTPTPN1
SCHEMBL1066415 1.00 FAAH (0.52) FAAHTRPV1NAAATERTPTPN1
SCHEMBL30767690 0.94 TRPV1 (0.52) TRPV1PPARGPPARDPPARAMAPT
SCHEMBL14177977 0.94 TRPV1 (0.52) TRPV1PPARGPPARDPPARAMAPT
SCHEMBL1891215 0.94 TRPV1 (0.52) TRPV1PPARGPPARDPPARAMAPT
SCHEMBL6746429 0.92 TRPV1 (0.53) FAAHTRPV1PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4544743-A Salts of 1,3,5-oxadiazines-2,4,6-triones, 1,3,5-oxadiazines-2,4,6-triones and the preparation thereof SOCIETE CARBOCHIMIQUE (BE) 1985-10-01 US claimed
US-11753496-B2 Softening composition COATEX (FR) 2023-09-12 US disclosed
CN-111433245-B Softening composition 可泰克斯公司 2022-12-20 CN disclosed
CN-111433245-A Softening composition 可泰克斯公司 2020-07-17 CN disclosed
EP-1287053-A1 URETHANE BASED ON ORGANOLEPTICALLY ACTIVE AROMATIC ALCOHOLS Henkel Kommanditgesellschaft auf Aktien (DE) 2003-03-05 EP disclosed
WO-2001094438-A1 URETHANE BASED ON ORGANOLEPTICALLY ACTIVE AROMATIC ALCOHOLS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-12-13 WO disclosed
US-4619917-A PLATELET ACTIVATING FACTOR INHIBITORS SANDOZ PHARM. CORP. (US) 1986-10-28 US disclosed
EP-0178261-A2 Substituted 2-furanyl or 5-oxo-2-furanyl-alkoxy phosphoryl alkyl cyclimmonium salts SANDOZ AG (CH) 1986-04-16 EP disclosed
US-4544743-A Salts of 1,3,5-oxadiazines-2,4,6-triones, 1,3,5-oxadiazines-2,4,6-triones and the preparation thereof SOCIETE CARBOCHIMIQUE (BE) 1985-10-01 US disclosed
US-4223145-A THERMAL DECOMPOSITION OF HYDROCHLORIDE OF TRISUBSTITUTED UREA AKZO N.V. (NL) 1980-09-16 US disclosed
US-4045483-A BACTERICIDES, FUNGICIDES STERLING DRUG INC. (US) 1977-08-30 US disclosed
US-4009163-A BACTERICIDES, FUNGICIDES STERLING DRUG INC. (US) 1977-02-22 US disclosed
US-3988370-A BACTERICIDES, FUNGICIDES STERLING DRUG INC. (US) 1976-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753496-B2 Softening composition KRT18, DSG1, XRCC6 FAAH 3009/4885TRPV1 2750/4885NAAA 1750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.